DK2029231T3 - Anvendelse af alfa-lactalbumin til regulering af glykæmi - Google Patents

Anvendelse af alfa-lactalbumin til regulering af glykæmi

Info

Publication number
DK2029231T3
DK2029231T3 DK07731348.4T DK07731348T DK2029231T3 DK 2029231 T3 DK2029231 T3 DK 2029231T3 DK 07731348 T DK07731348 T DK 07731348T DK 2029231 T3 DK2029231 T3 DK 2029231T3
Authority
DK
Denmark
Prior art keywords
lactalbumin
alpha
glycemic control
type
glycemia
Prior art date
Application number
DK07731348.4T
Other languages
English (en)
Inventor
Jean-Frana Ois Huneau
Benoa T Laplaize
Daniel Tome
Takashi Mikogami
Original Assignee
Cie Laitiere Europeenne
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cie Laitiere Europeenne filed Critical Cie Laitiere Europeenne
Application granted granted Critical
Publication of DK2029231T3 publication Critical patent/DK2029231T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/38—Albumins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/19—Dairy proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Obesity (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Zoology (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Polyamides (AREA)
DK07731348.4T 2006-04-27 2007-04-24 Anvendelse af alfa-lactalbumin til regulering af glykæmi DK2029231T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0603810A FR2900342B1 (fr) 2006-04-27 2006-04-27 Utilisation de l'alpha-lactalbumine pour la regulation de la glycemie
PCT/FR2007/000689 WO2007128901A1 (fr) 2006-04-27 2007-04-24 Utilisation de l'alpha-lactalbumine pour la regulation de la glycemie

Publications (1)

Publication Number Publication Date
DK2029231T3 true DK2029231T3 (da) 2012-02-27

Family

ID=37478857

Family Applications (1)

Application Number Title Priority Date Filing Date
DK07731348.4T DK2029231T3 (da) 2006-04-27 2007-04-24 Anvendelse af alfa-lactalbumin til regulering af glykæmi

Country Status (10)

Country Link
US (1) US8648039B2 (da)
EP (1) EP2029231B1 (da)
AT (1) ATE531426T1 (da)
AU (1) AU2007247025B2 (da)
CA (1) CA2650495C (da)
DK (1) DK2029231T3 (da)
ES (1) ES2377015T3 (da)
FR (1) FR2900342B1 (da)
PL (1) PL2029231T3 (da)
WO (1) WO2007128901A1 (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110165138A1 (en) * 2008-06-26 2011-07-07 Healthlinx Limited Protocols for treating and preventing obesity and complications arising therefrom
GB0905555D0 (en) * 2009-03-31 2009-05-13 Peptcell Ltd Pharmaceutical agent
WO2010119088A2 (en) * 2009-04-15 2010-10-21 Bodo Melnik Milk and milk-based products modified to exhibit a reduced insulinemic index and/or reduced mitogenic activity
JP6842308B2 (ja) * 2017-01-31 2021-03-17 花王株式会社 夜間食後血糖上昇抑制剤
CN113827707B (zh) * 2021-09-30 2023-12-05 北京大学 a-乳白蛋白在抑制冠状病毒中的应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3343141A1 (de) * 1983-11-29 1985-06-05 Hermann P.T. 7400 Tübingen Ammon Verwendung von cystein-derivaten oder deren salzen, zur steigerung der insulinsekretion der langerhans'schen inseln der bauchspeicheldruese
EP0604684B1 (en) * 1992-12-23 1997-06-11 Campina Melkunie B.V. Process for the recovery of alpha-lactalbumin and beta-lactoglobulin from a whey protein product
IL126474A (en) * 1996-04-12 2001-03-19 Beth Israel Hospital Diabetic supplement bar
EP1228707A1 (en) * 2001-02-01 2002-08-07 Campina Melkunie B.V. Use of alpha-lactalbumin as prebiotic agent
US20020147153A1 (en) * 2001-02-14 2002-10-10 Functional Foods, Inc. Nutritional supplement to alleviate symptoms associated with reduced levels of serotonin
FR2875680B1 (fr) * 2004-09-29 2010-08-20 Veronique Marie-Pierre Peyrusson Compose dietetique pour combattre le syndrome metabolique

Also Published As

Publication number Publication date
CA2650495C (fr) 2016-01-05
PL2029231T3 (pl) 2012-05-31
AU2007247025A1 (en) 2007-11-15
ES2377015T3 (es) 2012-03-21
FR2900342A1 (fr) 2007-11-02
US8648039B2 (en) 2014-02-11
EP2029231A1 (fr) 2009-03-04
CA2650495A1 (fr) 2007-11-15
WO2007128901A1 (fr) 2007-11-15
EP2029231B1 (fr) 2011-11-02
FR2900342B1 (fr) 2010-08-20
ATE531426T1 (de) 2011-11-15
US20090325872A1 (en) 2009-12-31
AU2007247025B2 (en) 2013-01-10

Similar Documents

Publication Publication Date Title
WO2010049678A3 (en) Treatment of energy utilization diseases
EA200900626A1 (ru) Комбинированное лечение ингибиторами sglt-2 (натрийзависимый сопереносчик глюкозы 2) и содержащими их фармацевтическими композициями
BRPI0817239A2 (pt) Célula de combustível redox, e, solução de católito para uso em uma célula de combustível redox.
WO2010008739A3 (en) Aryl gpr119 agonists and uses thereof
MX2009011359A (es) Derivados de pirimidinona y sus metodos de uso.
WO2006105501A3 (en) Control of blood glucose in diabetes treatment using pulmonarily administered insulin in combination with basal insulin
WO2007024700A8 (en) Exendin for treating diabetes and reducing body weight
IL246402A (en) A therapeutic component for treating obesity, diabetes and impaired glucose tolerance
EP2217596B8 (en) Bicyclic heterocycle derivatives and their use as modulators of the activity of gpr119
NZ595344A (en) Drug fusions and conjugates
WO2006044531A3 (en) Antisense modulation of ptp1b expression
BRPI0909035A2 (pt) Uma composição cimentosa auto-niveladora com taxa controlada de desenvolvimento de resistência e resistência compressiva ultra- elevada no endurecimento e artigos produzidos a partir da mesma.
EP1845105A4 (en) MODIFIED EXENDINES AND CORRESPONDING USES
NZ608829A (en) Pharmaceutical composition comprising an sglt2-inhibitor, methods for treating and uses thereof
AU2009278929A8 (en) Pyrazolo [3,4] pyrimidin-4-yl derivatives and their uses to treat diabetes and obesity
EP2361618A3 (en) Compositions for treating or preventing obesity and insulin resistance disorders
WO2009026517A3 (en) Therapy for complications of diabetes
BRPI0814931A2 (pt) Composto com atividade contra hcv, sua composição e seu uso
PL2029231T3 (pl) Zastosowanie alfa-laktalbuminy w regulacji glikemii
MX2008004734A (es) Composicion rica en leucina.
WO2005113016A3 (en) Modulation of glucose-6-phosphatase translocase expression
WO2009143065A3 (en) Rice bran extracts and methods of use thereof
ATE496890T1 (de) Pyridinderivate für die behandlung von stoffwechselstörungen, die mit insulinresistenz oder hyperglykämie in zusammenhang stehen
CL2007002516A1 (es) Compuestos derivados de indol indano; composicion farmaceutica; y su uso para tratar hiperglicemia, diabetes tipo 2, tolerancia deteriorada a la glucosa, resistencia a la insulina, sindrome x, dislipidemia.
WO2009046015A3 (en) Combination therapies for treating type 1 diabetes